TBCRC 024 Initial Results: A Multicenter Phase 1 Study of Veliparib Administered Concurrently With Chest Wall and Nodal Radiation Therapy in Patients With Inflammatory or Locoregionally Recurrent Breast Cancer
Publication
, Conference
Jagsi, R; Griffith, KA; Bellon, JR; Woodward, WA; Horton, JK; Ho, AY; Schott, A; Pierce, LJ
Published in: International Journal of Radiation Oncology*Biology*Physics
November 2015
Duke Scholars
Published In
International Journal of Radiation Oncology*Biology*Physics
DOI
ISSN
0360-3016
Publication Date
November 2015
Volume
93
Issue
3
Start / End Page
S137 / S137
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Jagsi, R., Griffith, K. A., Bellon, J. R., Woodward, W. A., Horton, J. K., Ho, A. Y., … Pierce, L. J. (2015). TBCRC 024 Initial Results: A Multicenter Phase 1 Study of Veliparib Administered Concurrently With Chest Wall and Nodal Radiation Therapy in Patients With Inflammatory or Locoregionally Recurrent Breast Cancer. In International Journal of Radiation Oncology*Biology*Physics (Vol. 93, pp. S137–S137). Elsevier BV. https://doi.org/10.1016/j.ijrobp.2015.07.326
Jagsi, R., K. A. Griffith, J. R. Bellon, W. A. Woodward, J. K. Horton, A. Y. Ho, A. Schott, and L. J. Pierce. “TBCRC 024 Initial Results: A Multicenter Phase 1 Study of Veliparib Administered Concurrently With Chest Wall and Nodal Radiation Therapy in Patients With Inflammatory or Locoregionally Recurrent Breast Cancer.” In International Journal of Radiation Oncology*Biology*Physics, 93:S137–S137. Elsevier BV, 2015. https://doi.org/10.1016/j.ijrobp.2015.07.326.
Jagsi R, Griffith KA, Bellon JR, Woodward WA, Horton JK, Ho AY, et al. TBCRC 024 Initial Results: A Multicenter Phase 1 Study of Veliparib Administered Concurrently With Chest Wall and Nodal Radiation Therapy in Patients With Inflammatory or Locoregionally Recurrent Breast Cancer. In: International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2015. p. S137–S137.
Jagsi, R., et al. “TBCRC 024 Initial Results: A Multicenter Phase 1 Study of Veliparib Administered Concurrently With Chest Wall and Nodal Radiation Therapy in Patients With Inflammatory or Locoregionally Recurrent Breast Cancer.” International Journal of Radiation Oncology*Biology*Physics, vol. 93, no. 3, Elsevier BV, 2015, pp. S137–S137. Crossref, doi:10.1016/j.ijrobp.2015.07.326.
Jagsi R, Griffith KA, Bellon JR, Woodward WA, Horton JK, Ho AY, Schott A, Pierce LJ. TBCRC 024 Initial Results: A Multicenter Phase 1 Study of Veliparib Administered Concurrently With Chest Wall and Nodal Radiation Therapy in Patients With Inflammatory or Locoregionally Recurrent Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2015. p. S137–S137.
Published In
International Journal of Radiation Oncology*Biology*Physics
DOI
ISSN
0360-3016
Publication Date
November 2015
Volume
93
Issue
3
Start / End Page
S137 / S137
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences